BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 4, 2025
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
EMA's CHMP issues positive opinion on Relistor in prefilled syringes
Aug. 6, 2010
COMP recommends orphan drug status for XOMA-052 in Behcet's disease
July 30, 2010
Bionovo moves Menerba to phase III testing in Europe
July 30, 2010
CHMP issues positive opinion on Arixtra use for superficial vein thrombosis
July 27, 2010
CHMP issues positive opinion on Twynsta for hypertension
July 26, 2010
EMA provides update on benefit-to-risk review of Avandia, Avandamet and Avaglim
July 26, 2010
EMA recommends restricting modafinil use
July 26, 2010
CHMP concludes topical ketoprofen has positive benefit-to-risk balance
July 23, 2010
FDA recommends further naproxcinod trials in complete response letter to NicOx
July 22, 2010
Global registrational trial announced for rFVIIIFc in hemophilia A
July 12, 2010
Previous
1
2
…
137
138
139
140
141
142
143
144
145
…
155
156
Next